G1 Therapeutics, Inc. (GTHX)

G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 17, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	378	158	275	434	684	993
Market Cap Growth	-	-42.46%	-36.70%	-36.57%	-31.09%	39.49%
Enterprise Value	365	120	234	259	475	704
Last Close Price	-	3.05	5.43	10.21	17.99	26.43
PE Ratio	-	-3.28	-1.61	-2.88	-6.87	-8.09
PS Ratio	6.40	1.92	5.36	13.79	15.11	-
PB Ratio	15.32	4.47	4.00	3.02	3.86	3.89
P/FCF Ratio	-	-4.12	-2.13	-3.29	-8.17	-9.71
P/OCF Ratio	-	-4.12	-2.14	-3.29	-8.17	-9.98
EV/Sales Ratio	6.28	1.45	4.57	8.24	10.49	-
EV/EBITDA Ratio	-	-3.07	-1.73	-1.83	-4.95	-5.47
EV/EBIT Ratio	-	-3.03	-1.72	-1.82	-4.92	-5.45
EV/FCF Ratio	-	-3.12	-1.81	-1.96	-5.67	-6.88
Debt / Equity Ratio	1.95	1.62	1.20	0.57	0.16	0.04
Debt / FCF Ratio	-1.28	-1.49	-0.64	-0.62	-0.33	-0.10
Asset Turnover	0.47	0.53	0.23	0.13	0.18	-
Inventory Turnover	0.42	0.50	0.38	-	-	-
Quick Ratio	1.97	3.19	4.39	8.22	8.85	13.62
Current Ratio	2.48	3.87	5.04	8.82	9.23	13.71
Return on Equity (ROE)	-109.01%	-92.13%	-139.02%	-92.46%	-45.86%	-39.86%
Return on Assets (ROA)	-19.20%	-15.96%	-38.51%	-36.89%	-23.49%	-24.58%
Return on Invested Capital (ROIC)	-25.45%	-20.25%	-45.17%	-41.36%	-25.61%	-25.83%
Earnings Yield	-11.84%	-30.34%	-53.69%	-34.17%	-14.50%	-12.33%
FCF Yield	-9.93%	-24.25%	-46.99%	-30.43%	-12.23%	-10.30%
Buyback Yield / Dilution	-8.23%	-18.58%	-4.01%	-10.73%	-1.01%	-12.55%
Total Shareholder Return	-8.23%	-18.58%	-4.01%	-10.73%	-1.01%	-12.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q